David Hurley

David Hurley has over 30 years of experience in the healthcare industry. In 1989, they began their career as the Vice President of International Business at Fujisawa Pharmaceuticals, which is now known as Astellas Pharma. In 1994, they became the CEO of Novartis Nutrition, where they managed a sales team of over 250 and an overall employee base of over 1000. From 1997 to 2000, they served as the CEO of Sandoz Pharmaceuticals, a global leader in generic pharmaceuticals and biosimilars. In 2000, they were the CEO of HealthNexis, which merged with Global Health Exchange. From 2002 to 2015, they were the President of Pharmaceuticals Division and COO of Alcami Corporation, and then the CEO of LifeMed ID and LifeNexis. From 2016 to 2018, they were the CEO of Wellvii Inc, where they worked closely with the Chief Technology Officer on building a strategic partnership with Motorola to provide consumers with a mobile platform that measures six critical vital signs in less than 3 minutes. In 2018, they became the CEO of MandaraRX.

David Hurley obtained their Bachelor of Science (B.S.) in Marketing and Economics from the University of Iowa between 1978 and 1982. David then went on to pursue a Master of Business Administration (M.B.A.) in International Business at Thunderbird School of Global Management between 1982 and 1984. In 1999 and 2000, they attended Harvard University for the Novartis Executive Management Program, studying in Shanghai, Switzerland and Boston.